The National Institute for Health Research (NIHR) supports the funding and delivery of clinical research in health and social care in England. Investment in cancer research remains a priority. Last year over 1,000 cancer research studies were carried out with NIHR's support. This includes the essential contribution to research being carried out in hospices and community care.
In his debut blog for Social Care News, Professor Emeritus Sam H Ahmedzai, NIHR National Specialty Lead for Cancer, highlights how NIHR is helping to increase activity in these areas.
In Britain we are proud of our palliative care services for patients with advancing progressive diseases such as cancer, and who are at the end of life.
We have led the world in the development of supportive and palliative care services, including standalone in-patient hospice units and multidisciplinary teams embedded in NHS hospitals, and more recently through community teams extending care into people’s own homes and care homes.
Whereas much of the headline-grabbing research is centred on advances in cancer diagnosis and treatments, which usually occur in a hospital setting, there is a recognised need for research to improve the quality of life of patients (and their carers) once they have finished their treatment and have left hospital. This includes supportive and palliative care research.
The NIHR and a number of charities have increased funding and other forms of support towards boosting research in this important aspect of a cancer patient’s journey.
However, in my role as National Specialty Lead, I believe there is so much more we can do to improve the evidence base, especially by engaging clinicians working in hospices and community settings to contribute to this research endeavour.
This is why our team at the NIHR have initiated the Consortium for Hospice and Community Research.
The Consortium was first launched in April 2017 with the aim to make the UK a global leader in palliative care research within five years. We’re partnering with Hospice UK, Macmillan, Maggie’s, Marie Curie, NCRI, Target Ovarian Cancer, Sue Ryder and Teenage Cancer Trust.
The Consortium’s ambitious objectives include:
- Increasing the portfolio of studies involving recruitment from the hospice and community sectors by five per cent per annum.
- Patients or carers to be recruited into NIHR Portfolio studies from every hospice in the UK each year by 2022.
- To publish at least one practice-changing piece of research for the care of cancer and palliative care patients in the hospice and community setting each year by 2022.
I chaired the Consortium’s first conference this year, opened by Baroness Julia Neuberger who played a key role in the Consortium’s establishment.
It was great to hear from members of the public living with cancer who showcased research projects they had been working on with partners and internationally recognised teams and hospices which were awarded for major progress in research activity.
Partners gave updates on their progress towards meeting the Consortium’s objectives, and researchers presented numerous examples of NIHR Portfolio studies which strive to improve care for patients and their families. It was a very productive day and we are already planning the next.
This month our team is supporting World Hospice and Palliative Care Day #WHPCDay18 #BecauseIMatter by raising awareness that research can and should take place in hospice and community settings and by encouraging health and social care staff, patients and carers to get involved.
Our campaign page includes a map of research active hospices across the UK, research statistics, a Q&A with Macmillan and Marie Curie and videos at research active hospices with staff, a patient and carer. Visit Because I Matter to find out more and get involved.